News | August 18, 2023
BASF, Promega and Swiss TPH collaborate to drive research for malaria control
Proteolysis Targeting Chimeras (PROTACs) technology as potential new method for mosquito-borne disease control
Proteolysis Targeting Chimeras (PROTACs) technology as potential new method for mosquito-borne disease control
Take proper precautions and seek timely treatment!
Currently there are no vaccines approved anywhere in the world for gonorrhoea, and antimicrobial resistance to existing treatments is increasing
Azithromycin Tablets USP, 500 mg had annual sales of US $20 million in the United States
The Indian government will float a global tender in April 2023 to procure HPV vaccines.
In a time when conversations around mental health have become ever more urgent Vaidya’s work is extremely contextual
MVUs will provide diagnosis treatment, vaccination, artificial insemination, minor surgical interventions, audio-visual aids and extension services to farmers/animal owners at their doorstep in far flung areas.
Gates Frontier, Bezos Expeditions, Reliance Digital Health Limited, Greenoaks, Alumni Ventures, Moore Strategic Ventures, and Project X join ARCH as new additional investors
If approved, TAK-003 has the potential to become an important dengue prevention option for healthcare providers
The core of “LANXESS Biosecurity Solutions” is a portfolio of scientifically formulated, highly effective and versatile biocidal products
Subscribe To Our Newsletter & Stay Updated
